|
| | Publication Year | Title | Author(s) |
| 141 | 1-Jul-2019 | Cardiometabolic Effects of Endocrine Treatment of Estrogen Receptor-Positive Early Breast Cancer. | Cheung, Yee-Ming Melody ; Ramchand, Sabashini K ; Yeo, Belinda ; Grossmann, Mathis |
| 142 | Jun-2019 | Right or Left Primary Site of Colorectal Cancer: Outcomes From the Molecular Analysis of the AGITG MAX Trial. | Tapia Rico, Gonzalo; Price, Timothy; Tebbutt, Niall C ; Hardingham, Jennifer; Lee, Chee; Buizen, Luke; Wilson, Kate; Gebski, Val; Townsend, Amanda |
| 143 | 16-Apr-2019 | Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial. | Eng, Cathy; Kim, Tae Won; Bendell, Johanna; Argilés, Guillem; Tebbutt, Niall C ; Di Bartolomeo, Maria; Falcone, Alfredo; Fakih, Marwan; Kozloff, Mark; Segal, Neil H; Sobrero, Alberto; Yan, Yibing; Chang, Ilsung; Uyei, Anne; Roberts, Louise; Ciardiello, Fortunato |
| 144 | Apr-2019 | Entrectinib in NTRK fusion-positive non-small cell lung cancer (NSCLC): Integrated analysis of patients (pts) enrolled in STARTRK-2, STARTRK-1 and ALKA-372-001. | Paz-Ares, L; Doebele, R C; Farago, A F; Liu, S V; Chawla, S P; Tosi, D; Blakely, C M; Krauss, J C; Sigal, D; Bazhenova, L; John, Thomas ; Besse, B; Wolf, J; Seto, T; Chow-Maneval, E; Ye, C; Simmons, B; Demetri, G D |
| 145 | Apr-2019 | Entrectinib in locally advanced or metastatic ROS1 fusion-positive non-small cell lung cancer (NSCLC): Integrated analysis of ALKA-372-001, STARTRK-1 and STARTRK-2. | Barlesi, F; Drilon, A; De Braud, F; Cho, B C; Ahn, M J; Siena, S; Krebs, M G; Lin, C C; John, Thomas ; Tan, D S W; Seto, T; Dziadziuszko, R; Arkenau, H-T; Rolfo, C; Wolf, J; Ye, C; Riehl, T; Eng, S; Doebele, R C |
| 146 | 27-Mar-2019 | Epidermal growth factor receptor (EGFR)-targeted therapies in Mesothelioma. | Chia, Puey Ling ; Scott, Andrew M ; John, Thomas |
| 147 | Feb-2019 | Real-world efficacy and toxicity of combined nivolumab and ipilimumab in patients with metastatic melanoma. | Parakh, Sagun ; Randhawa, Manreet; Nguyen, Bella; Warburton, Lydia; Hussain, Mohammad Akhtar; Cebon, Jonathan S ; Millward, Michael; Yip, Desmond; Ali, Sayed |
| 148 | 2019 | Ectopic breast cancer in the inguinal region. | Loh, Zoe ; Yeo, Belinda ; Williams, David S ; Gyorki, David E |
| 149 | 2019 | The effects of adjuvant endocrine therapy on bone health in women with breast cancer. | Ramchand, Sabashini K ; Cheung, Yee-Ming Melody ; Yeo, Belinda ; Grossmann, Mathis |
| 150 | Dec-2018 | Perspective: cancer vaccines in the era of immune checkpoint blockade. | Cebon, Jonathan S |
| 151 | Dec-2018 | Cetuximab Alone or With Irinotecan for Resistant KRAS-, NRAS-, BRAF- and PIK3CA-wild-type Metastatic Colorectal Cancer: The AGITG Randomized Phase II ICECREAM Study. | Shapiro, Jeremy D; Thavaneswaran, Subotheni; Underhill, Craig R; Robledo, Kristy P; Karapetis, Christos S; Day, Fiona L; Nott, Louise M; Jefford, Michael; Chantrill, Lorraine A; Pavlakis, Nick; Tebbutt, Niall C ; Price, Timothy J; Khasraw, Mustafa; Van Hazel, Guy A; Waring, Paul M; Tejpar, Sabine; Simes, John; Gebski, Val J; Desai, Jayesh; Segelov, Eva |
| 152 | Dec-2018 | Elderly patients with stage III NSCLC survive longer when chemotherapy is added to radiotherapy-fortune favours the bold. | Arulananda, Surein; Mitchell, Paul L R |
| 153 | Dec-2018 | EGFR mutation analysis for prospective patient selection in AURA3 phase III trial of osimertinib versus platinum-pemetrexed in patients with EGFR T790M-positive advanced non-small-cell lung cancer. | John, Thomas ; Akamatsu, Hiroaki; Delmonte, Angelo; Su, Wu-Chou; Lee, Jong Seok; Chang, Gee-Chen; Huang, Xiangning; Jenkins, Suzanne; Wu, Yi-Long |
| 154 | Nov-2018 | Clinicopathological differences and survival outcomes with first-line therapy in patients with left-sided colon cancer and rectal cancer: Pooled analysis of 2879 patients from AGITG (MAX), COIN, FOCUS2, OPUS, CRYSTAL and COIN-B trials in the ARCAD database. | Salem, Mohamed E; Yin, Jun; Weinberg, Benjamin A; Renfro, Lindsay A; Pederson, Levi D; Maughan, Timothy S; Adams, Richard A; Van Cutsem, Eric; Falcone, Alfredo; Tebbutt, Niall C ; Seymour, Matthew T; Díaz-Rubio, Eduardo; Aranda, Enrique; Bokemeyer, Carsten; Heinemann, Volker; Wasan, Harpreet; de Gramont, Aimery; Grothey, Axel; Shi, Qian; Sargent, Daniel J; Marshall, John L |
| 155 | Oct-2018 | Clinical correlates of severe thrombocytopenia from temozolomide in glioblastoma patients. | Arulananda, Surein; Lynam, James; Sem Liew, Mun; Wada, Morikatsu ; Cher, Lawrence; Gan, Hui K |
| 156 | Oct-2018 | Targeted therapy for metastatic colorectal cancer. | Price, Timothy J; Tang, Monica; Gibbs, Peter; Haller, Daniel G; Peeters, Marc; Arnold, Dirk; Segelov, Eva; Roy, Amitesh; Tebbutt, Niall C ; Pavlakis, Nick; Karapetis, Chris; Burge, Matthew; Shapiro, Jeremy |
| 157 | Sep-2018 | Echocardiography has low utility in cancer patients with Staphylococcus aureus bacteraemia: findings from a retrospective study. | Loh, Zoe ; Estacio, Ortis; Grigg, Andrew P ; Holmes, Natasha E ; Chong, Geoff; Hawkes, Eliza A |
| 158 | Aug-2018 | BRAF Mutations-A Good News Story for Immune Checkpoint Inhibitors in Oncogene-Addicted NSCLC? | Arulananda, Surein; Mitchell, Paul L R |
| 19 | Jul-2018 | Molecular imaging of T cell co-regulator factor B7-H3 with 89Zr-DS-5573a. | Burvenich, Ingrid J G; Parakh, Sagun ; Lee, Fook-Thean; Guo, Nancy; Liu, Zhanqi; Gan, Hui K ; Rigopoulos, Angela; O'Keefe, Graeme Joseph; Gong, Sylvia Jie; Goh, Yit Wooi; Tochon-Danguy, Henri; Scott, Fiona Elizabeth; Kotsuma, Masakatsu; Hirotani, Kenji; Senaldi, Giorgio; Scott, Andrew M |
| 20 | 19-Jun-2018 | Clinical correlates of severe thrombocytopenia from temozolomide in glioblastoma patients. | Arulananda, Surein; Lynam, James; Sem Liew, Mun; Wada, Morikatsu ; Cher, Lawrence M ; Gan, Hui K |
